Company: NCEL
Filing Date: 2025-06-23
Form Type: F-4/A
Source: 0001213900-25-056787
Chunk: 765

Company: NewcelX Ltd.
Filing Date: 2025-06-23
Form: F-4/A
Chunk 765
---
 of approval of the 
 financial statements    |     | Ronen Twito       
 CEO and Executive 
 Chairman of BOD   |     | Liora Oren     
 Director       |     | Uri Ben Or     
 CFO            |

The accompanying Notes are an integral part of the financial statements.

Annex G-3

KADIMASTEM LTD.
Statements of Profit or Loss and Other Comprehensive Loss

|                                                                                                                             |     | Note |     |                  Year ended December 31, 
                                     2024 |   |     |  2023 |   |     |  2022 |   |
|:----------------------------------------------------------------------------------------------------------------------------|:----|-----:|:----|-----------------------------------------:|:--|:----|------:|:--|:----|------:|:--|
|                                                                                                                             |     |      |     | USD in thousands (except per share data) |   |     |       |   |     |       |   |
| Research and development expenses                                                                                           |     |  20a |     |                                      992 |   |     | 1,608 |   |     | 4,490 |   |
| Marketing expenses                                                                                                          |     |  20b |     |                                        — |   |     |    81 |   |     |   264 |   |
| General and administrative expenses                                                                                         |     |  20c |     |                                      793 |   |     | 1,303 |   |     | 1,800 |   |
| Other expenses (expenses for merger with NLS)                                                                               |     |      |     |                                      269 |   |     |     — |   |     |     — |   |
| Operating loss                                                                                                              |     |      |     |                                    2,054 |   |     | 2,992 |   |     | 6,554 |   |
| Financing income                                                                                                            |     |  20d |     |                                       (6 | ) |     |   (36 | ) |     |   (22 | ) |
| Financing expenses related to the conversion component and options of shareholders convertible loans and shareholder loans. |     |  20d |     |                                    5,044 |   |     |   239 |   |     |   200 |   |
| Other financing expenses                                                                                                    |     |      |     |                                       93 |   |     |   114 |   |     |